ByteBrief
We're a portrait publication through and through. Turn your phone back and your briefing picks up right where you left it.
(We tried widescreen once. It wasn't us.)
Transcripta Bio raised $24 million in funding. The company focuses on drug discovery using AI and genomics. The financing will support the development of its platform for identifying new therapeutic targets.
Tap to vote and see what everyone thinks.
Summary by ByteBrief
Sightera Biosciences Raises €3M in Pre-Seed Funding